US Department of Defense
BLAST INJURY RESEARCH
COORDINATING OFFICE
Advancing Blast Injury Research to Protect and Heal Those Who Serve

8th International Forum on Blast Injury Countermeasures (IFBIC 2024)

1-3 May, 2022

IFBIC logo

Objective and Scope

In recent years, attacks using explosive devices occur frequently, not only on battlefields and in regions of conflict, but also in urban areas in peacetime due to terrorism, resulting in a large number of blast injury victims. The US Department of Defense uses the Taxonomy of Injuries from Explosive Devices (as described in DoDD 6025.21E) to organize blast injuries into five groupings based on their approximate order of temporal incidence upon the body following an explosion. Primary injuries result from the blast shock wave. Secondary injuries result from penetrating fragments of material accelerated by the blast. Tertiary injuries result from accelerative loading or blunt impact to tissues. Quaternary injuries include dermal burns and toxic gas inhalation. Quinary injuries include contamination by nuclear, chemical, or biological agents. Primary injuries that are peculiar to blast shockwave exposures include mild blast-induced traumatic brain injury (bTBI), hearing loss, ocular injury, and lung injury. All body systems are vulnerable to secondary injuries due to penetrating fragments and tertiary injuries due to acceleration and blunt force trauma.

International cross-disciplinary collaboration is regarded as essential to investigate physical causes of blast injury, to characterize the vulnerability of anatomical systems and their functions to blasts, and to develop the means to prevent, mitigate, and treat blast injuries. Countermeasures may include personal protective equipment; weapons and vehicle systems engineered for safety; tactics, techniques, and procedures (TTPs) for injury prevention; and medical interventions tailored to the specific needs of blast injuries.

This International Forum on Blast Injury Countermeasures (IFBIC) started as Technical Information Exchange Forum between Japan and the United States, which brought together broad knowledge and expertise, and to share national experiences and evidence-based approaches for blast injuries. The former three Japan-US Technical Information Exchange Forum on Blast Injury (JUFBI) were held in June 2016, April 2017 and May 2018, all in Tokyo. At the end of JUFBI 2018, the organizing committee decided to change the forum name to International Forum on Blast Injury Countermeasures to reflect the expanding participation by additional nations such as Australia, Canada, Germany, South Korea and the United Kingdom. IFBIC 2023 was held in Tokyo, Japan.

These meetings have been very productive, involving active and fruitful discussions and exchange of creative ideas on a broad spectrum of blast injuries; identifying critical issues involving experimental and computational studies of blast-induced injuries; and creating new partnerships on joint research explorations to address the many scientific and technical challenges facing the field.

Building upon these successful meetings, the next IFBIC will be held from 1 – 3 May 2024 at The MITRE Corporation in McLean, Virginia.

The objectives for the 8th Forum include:

  1. Assembly of an international forum focused on multi-disciplinary science and medicine necessary to increase our understanding of blast injury and its countermeasures from bench to bedside
  2. Achieving a mutual understanding of international efforts in blast injury research
  3. Identifying knowledge gaps requiring collaborative research
  4. Increasing understanding and promoting further collaboration to improve prevention, clinical diagnosis, and treatment addressing the entire spectrum of blast-related injuries

The meeting agenda includes the following broad topic areas. Innovative research beyond this topic list will also be considered:

  1. Blast injury epidemiology and environmental sensing of blast shockwave hazards
    1. Clinical prevalence of varieties of blast injuries sorted by context, anatomy, and severity
    2. Blast energy / physics / waveforms, reflections, effects of media (e.g., air vs. water vs. solid material)
    3. Blast sensor engineering, test and evaluation, fidelity, usability
    4. Correlation of blast sensing with clinical outcomes
    5. Use of multiple sensors to reconstruct blast phenomena
  2. Primary blast injury (due directly to shockwave effects)
    1. Experimentally derived injury risk criteria for anatomical structures and their functions, including brain, ocular, auditory, and lung
    2. Predicted incapacitation due to blast injuries (e.g., loss of neuromuscular control, reduced sensory or cognitive function, reduced respiration)
  3. Secondary (penetrating ballistic fragments) and tertiary (acceleration and blunt force) blast injury
    1. Experimentally derived injury risk criteria for anatomical structures and their functions
    2. Predicted incapacitation due to blast injuries (e.g., loss of musculoskeletal force)
  4. Long-term effects, cumulative effects, and chronic symptoms due to blast exposure
    1. Brain: aberrant protein expression and accumulation (e.g., phosphorylated Tau)
    2. Brain: chronic traumatic encephalopathy (CTE)-like symptoms
    3. Brain: correlation and comorbidity with post-traumatic stress disorder (PTSD)
    4. Effect of cumulative subclinical (i.e., not provoking diagnosis) exposures to blast phenomena for all body systems
    5. Effect of repeated clinical (i.e., provoking diagnosis) exposures to blast phenomena for all body systems
  5. Prevention, mitigation, treatment of blast injuries
    1. Personal protective equipment (PPE) such as helmets, body armor, eye protection, hearing protection, etc.
    2. Weapon and vehicle systems engineered for safety in blast environments
    3. Tactics, techniques, and procedures (TTPs) for Warfighter safety in blast environments
    4. Operational mission planning for needed medical response
    5. Lessons learned from military operations
    6. Resilience training (e.g., stress inoculation, mindfulness-based cognitive therapies to prevent sequelae of psychological trauma from blast exposures)
    7. Biomedically-based design and acquisition standards for military equipment (materiel)
    8. Biomedically-based health hazard assessments
    9. Clinical current practices, interventions, surgeries, rehabilitative therapies
  6. Diagnostic measures / biomarkers
    1. Innovations in self-reported symptom inventories
    2. Innovations in diagnostics based on observations by clinical staff
    3. Innovations in molecular markers of blast injury
    4. Innovations in biomedical imaging measures of blast injury
    5. Innovations in behavioral or functional tests for blast injury
  7. Computational modeling and simulation of blast phenomena and blast injury
    1. Deformable finite element modeling (FEM) of stresses and strains
    2. Injury risk criteria applied to force-time histories from FEM
    3. Incapacitation risk criteria applied to injury predictions from FEM
    4. Shockwave modeling
    5. Innovations in coupling between computational fluid dynamics (CFD) and FEM
    6. Integration of computational models with blast sensors and other sensors (e.g, strain gauges or force transducers on cadavers or simulant manikins)
  8. Characteristics comparisons between blast-related TBI and blunt TBI
  9. New technology and methods for blast injury research and medicine

Contributions from all countries, as well as from young investigators, are welcome.

General Information

Meeting title:
The 8th International Forum on Blast Injury Countermeasures (IFBIC 2024)

Organized by:
U.S. Army Medical Research and Development Command (USAMRDC)
U.S. Army Combat Capabilities Development Command (USA CCDC DEVCOM-ARL)
National Defense Medical College Japan (NDMC)

A closed meeting for planning committee members will be held on Monday, 6 May 2024 at The MITRE Corporation in McLean, Virginia following the main portion of the meeting.

Venue:
MITRE Corporation Headquarters, Building 4, Robb Conference Room, 7515 Colshire Drive, McLean VA 22102 USA

Abstract Submission

Please prepare your abstract using the template provided at the conference website and the attachment template. Abstract submissions should be emailed or faxed directly to the IFBIC point of contact no later than close of business 28 February 2024, 5:00 p.m. U.S. Eastern Standard Time.

IFBIC 2024 Point of Contact e-mail:
IFBIC@mitre.org

All submitted abstracts will be reviewed by the IFBIC 2024 Program Committee and notification of abstract acceptance will be made by 14 March 2024. NOTE: Priority will be given to submitted abstracts that contain original findings that have not been reported in previous IFBIC forums. Prior research reported at IFBIC may always be included as background information in support of original findings that are new to the IFBIC venue.

Registration

Pre-registration is required for all participants, and participation will be limited by venue capacity. The pre-registration deadline is 1 April 2024. The meeting registration will be open for registration on or after February 5, 2024.

"On-site" meeting registration will not be offered.

There is no registration fee. An optional meeting expense charge of $140 USD will be collected online, or in person upon arrival as part of the pre-registration process. Due to the lack of restaurants convenient to the meeting location, meeting attendees are encouraged to sign up for catered lunch and refreshments provided on-site. This charge covers hot and cold beverages including coffee, green tea, snacks, and lunch during the three meeting days and the social gathering the first evening. Options will be available on-site for gluten-free, dairy-free, vegetarian, and vegan dietary restrictions. Registration for catering is done using the meeting registration.

IFBIC 2024 Point of Contact e-mail:
IFBIC@mitre.org

Hotel Accommodations

For the participants who wish to stay near the Forum venue, a block of rooms have been reserved at both the Residence Inn Tysons Corner Mall and at the Archer Tysons Hotel. A list of other hotels in the area is also available on the registration website. Please be advised that May is a busy time in Washington, DC and rooms should be booked early.

Hotel Information:
You may contact the Residence Inn Tysons Corner directly at (703) 917-0800 or the Archer Tysons Hotel directly at (703) 912-0488 to reserve a room within the group block by mentioning that you are reserving with the 'IFBIC 2024' group or use the following reservation links:

Keynote and Tutorial Speakers

Keynote speakers will be announced closer to the meeting date.

Tutorial speakers have not yet been selected. If you would like to lead a tutorial session, please submit a separate abstract for your proposed tutorial. Abstracts for tutorial sessions must provide a title that begins with the word, "Tutorial:". Abstract submission for tutorial sessions must follow the same guidelines as those for regular presentations, as described in the "Abstract Submission" section above.

Social Gathering

Optional evening social events include a meet-and-greet social with hors d'oeuvres the evening of Wednesday 1 May. All food service will provide on-site options for gluten-free, dairy-free, vegetarian, and vegan dietary restrictions. Costs of attendance are included in your participation fee for the Forum.

Meeting Organization Committee

General Chair:
Jacob (Jake) Johnson (USAMRDC, USA)
General Co-Chair:
Satoshi Tomura (NDMC, Japan)
Program Chair:
Raj Gupta (USAMRDC, USA)
Program Co-Chair:
Satoko Kawauchi (NDMC, Japan)
Members:
James Batchelor (Univ. of Southampton, UK)
Thomas DeGraba (NICoE, USA)
Lt. Colonel Dr. Steffen Grobert (DEU Medical Command, Germany)
Yasuyuki Honda (OASDHA, USA)
Shashi Karna (USACCDC Army Research Laboratory, USA)
Emrys Kirkman (DSTL, UK)
Nobuaki Kiriu (NDMC, Japan)
Yutaka Kodama (USACCDC DEVCOM, International Technology Center-Pacific (ITC-PAC), USA)
Adam Lewis (USAMRDC, USA)
Izumi Nishidate (TUAT, Japan)
Masayuki Ohta (NDMC, Japan)
Thuvan Piehler (USAMRDC, USA)
Masaki Takeda (ATLA, Japan)
Yuya Tanaka (JGSDF & MoD, Japan)
Akimasa Tashiro (NDMC, Japan)
Satoshi Tomura (NDMC, Japan)
Olivia Webster (DCPH-A, USA)
Therese West (USAMRDC, USA)
Meeting Secretaries:
Adam Lewis (USAMRDC)
Raj Gupta (USAMRDC, USA)
Satoko Kawauchi (NDMC, Japan)

Contact/Questions

LTC Adam Lewis (USAMRDC, USA)
Brain Health Coordinator
DoD Blast Injury Research Coordinating Office
US Army Medical Research and Development Command
504 Scott Street, Fort Detrick, MD 21702
Telephone: (301) 619-7376
Email: adam.b.lewis.mil@health.mil

Raj Gupta, Ph.D., BCE
Deputy Director
DoD Blast Injury Research Program Coordinating Office
US Army Medical Research and Development Command
504 Scott Street, Fort Detrick, MD 21702
Telephone: (301) 619-9838
Email: raj.k.gupta.civ@mail.mil
https://blastinjuryresearch.health.mil

Event Point-of-Contact (POC):
IFBIC@mitre.org

Partners and Sponsors

USAMRDC logo DHA logo National Defense Medical College of Japan logo US Army logo AFC logo DEVCOM logo
Last modified: 30-Oct-2024